Table 2.2.
the main laboratory tests and the positive rate of them in severe hepatitis patients with blood coagulopathy
| Name | Changes | Normal reference value | Positive rate when severe hepatitis occurring (%) |
|---|---|---|---|
| 1. Tests about clotting factors | |||
| PT | Lengthen | 11–13 s | 63–71 |
| APTT | >10s | (37 ± 3.3)s | 82–85 |
| INR | – | 1.0 ± 0.1 | >80 |
| HPT | Decrease | 90.1% ± 13.4% | 93 |
| Fz | Decrease | 2–4 g/L | 16–20 |
| Fγ:C | Increase | (103 ± 26)IU/L | 100 |
| TT | >3 s | 16–18 s | – |
| 2. Tests about anti-clotting factors | |||
| AT-β:A | Decrease | 108.5 ± 5.3% | 100 |
| PC:A | Decrease | 64–147% | 84 |
| 3. Tests about fibrinolysis | |||
| tPA | Increase | (0.3–0.6) IU/mL | 92 |
| PAI | Decrease | (0.1 ± 1.0)Au/mL | 76 |
| PLG:Ag | Decrease | (0.22 ± 0.03)g/L | 56 |
| PL;A |
Fibrinolysis: increase Hypercoagulability: Decrease |
85.5% ± 27.83% | – |
| a2-PI | Decrease | 0.8–1.2 inhibitory units/mL | 55 |
| 3P test | – | Negative | negative |
| ELT | Shorten (<70 min) |
Calcium addition method (129.8 ± 41.1)min Enzymolysis method (157.5 ± 59.1)min |
– |
| FDPs | Decrease | urine<10 mg/L | 85–90 |
| D-Dimer | Increase |
Negative (latex agglutination test) 0–0.256 mg/L (ELISA) |
9–15 |
| 4. Test about platelets quality and quantity | |||
| PLT | Decrease | (100–300) × 109/L | – |
| PAR | Decrease |
MAR (maximum aggregation rate) ADP (1.0 mmol/L)62.7% ± 16.1% ADP (0.5 mmol/L)37.4% ± 14.3% Adrenaline (0.4 mg/L)67.85% ± 17.8% |
– |
| PF3aT | Decrease | The recalcification time of group is under 5 s longer than that of group | – |
| CRT (whole blood method) | – | Clot retraction rate 65.8% ± 11.0%; Clot retracts partly after 2 h, and retracts completely after 18–24 h | – |